Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-012871
Filing Date
2021-07-01
Accepted
2021-07-01 18:58:01
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5815
  Complete submission text file 0001567619-21-012871.txt   7104
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON ST., 2ND FLOOR BOSTON MA 02116
Business Address
Namouni Fouad (Reporting) CIK: 0001815851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 211067515